Inc. (NARI) has reached a new 52-week high, with its stock price climbing to $79.7, marking a significant milestone for the ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from William Blair analyst Margaret Kaczor today. The ...

Inari Medical’s top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with venous thromboembolism (VTE) (with significant growth opportunities ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral. Analyst Price Forecast Suggests 14.00% Downside As of December 23, 2024, ...

Inari Medical (NARI – Research Report) received a Hold rating and price target from BTIG analyst Marie Thibault today. The company’s shares ...

It delivered a trailing four-quarter average earnings surprise of 24.77%. Inari Medical’s top-line growth is primarily driven by its ClotTriever and FlowTriever products that target patients with ...

Inari Medical (NASDAQ:NARI – Free Report) had its price target increased by Piper Sandler from $52.00 to $80.00 in a report issued on Tuesday morning,Benzinga reports. The brokerage currently has a ...

Baird R W cut shares of Inari Medical (NASDAQ:NARI – Free Report) from a strong-buy rating to a hold rating in a research note released on Tuesday morning,Zacks.com reports. Several other equities ...

On Tuesday, Baird analysts adjusted their stance on Inari Medical (TASE:PMCN) Inc. (NASDAQ:NARI), downgrading the stock from Outperform to Neutral and slightly reducing the price target to $80 ...

Inari Medical's shares are currently trading at ... outlook to between $601.5 million and $604.5 million. The company's ClotTriever Thrombectomy System for deep vein thrombosis has received ...

while Canaccord Genuity adjusted its stance on Inari Medical, downgrading it from Buy to Hold, but increasing the price target to $80.00. Inari's ClotTriever Thrombectomy System for deep vein ...

Inari Medical recently reported a record third-quarter revenue of $153.4 million, marking a 21% year-over-year increase. The company has also raised its full-year revenue outlook to between $601.5 ...